Gene Profiling in Ankylosing Spondylitis
Author Information
Author(s): Fernando M Pimentel-Santos, Dário Ligeiro, Mafalda Matos, Ana F Mourão, José Costa, Helena Santos, Anabela Barcelos, Fátima Godinho, Patricia Pinto, Margarida Cruz, João E Fonseca, Henrique Guedes-Pinto, Jaime C Branco, Matthew A Brown, Gethin P Thomas
Primary Institution: CEDOC, Faculdade de Ciências Médicas da Universidade Nova de Lisboa
Hypothesis
Can whole blood transcriptional profiling identify candidate genes associated with ankylosing spondylitis?
Conclusion
The study validated a gene expression signature for ankylosing spondylitis and identified strong candidate genes involved in inflammation and joint destruction.
Supporting Evidence
- 239 probes corresponding to 221 genes were identified as significantly different between patients and controls.
- Thirteen of the validated genes were downregulated 1.3- to 2-fold.
- The study utilized a multicenter approach with ethnically homogeneous patients.
Takeaway
Researchers looked at blood samples from people with ankylosing spondylitis to find genes that might be causing the disease, and they found some important ones.
Methodology
The study used whole-genome microarray analysis on blood samples from 18 active AS patients and 18 matched controls, followed by validation in a larger cohort using qPCR.
Potential Biases
Potential biases may arise from differences in blood collection and processing across multiple centers.
Limitations
The study may be limited by the small sample size and the potential for misclassification of samples.
Participant Demographics
18 active AS patients and 18 matched controls, with a second cohort of 78 AS patients and 78 controls.
Statistical Information
P-Value
<0.0005
Confidence Interval
80%
Statistical Significance
p<0.0005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website